MREO

Mereo BioPharma

53 hedge funds and large institutions have $84.3M invested in Mereo BioPharma in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

less funds holding

Funds holding:

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

57% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 21

Holders
53
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$775K
Puts
$28K
Net Calls
Net Calls Change

Top Sellers

1 -$5.48M
2 -$2.05M
3 -$1.69M
4
MAM
Monaco Asset Management
Monaco
-$806K
5
Citigroup
Citigroup
New York
-$799K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$15.3M
2
$9.72M
3
$9.3M
4
$7.3M
5
$7.13M
6
$4.93M
7
$4.69M
8
$4.01M
9
$2.97M
10
$2.62M
11
$2.57M
12
$2.35M
13
$2.33M
14
$2.05M
15
$1.33M
16
$1.26M
17
$932K
18
$463K
19
$438K
20
$401K
21
$300K
22
$261K
23
$240K
24
$225K
25
$208K